Increased malignancies in our Waikato cohort of patients with systemic sclerosis.
Monique S ReesChris FramptonDouglas H N WhiteKamal K SolankiPublished in: International journal of rheumatic diseases (2021)
This study found an increased risk of malignancy for patients within the Waikato SSc cohort. Risk was greater in male patients and the mean age of patients with malignancies was approximately 8 years older than those without malignancy.